Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 8—August 2011

Research

Novel Human Reovirus Isolated from Children with Acute Necrotizing Encephalopathy

Louise A. Ouattara, Francis Barin, Marie Anne Barthez, Bertrand Bonnaud, Philippe Roingeard, Alain Goudeau, Pierre Castelnau, Guy Vernet, Gláucia Paranhos-BaccalàComments to Author , and Florence Komurian-Pradel
Author affiliations: Author affiliations: Fondation Mérieux, Lyon, France (L.A. Ouattara, G. Vernet, G. Paranhos-Baccalà, F. Komurian-Pradel); Centre Hospitalier Universitaire Bretonneau (F. Barin, P. Roingeard, A. Goudeau); Institut National de la Santé et de la Recherche Médicale U966, Tours, France (F. Barin, P. Roingeard, A. Goudeau); Centre Hospitalier Universitaire, Clocheville, Tours (M.A. Barthez, P. Castelnau); bioMérieux SA, Marcy l’Etoile, France (B. Bonnaud)

Main Article

Table 2

Nucleotide and amino acid identities for segments of MRV2Tou05, a novel human type 2 reovirus, isolated from patient 2, with reovirus prototypes and SC-A strain*

MRV2Tou05 RNA segment
Reovirus prototype strain, %
Swine reovirus strain,
SC-A, %
T1L

T2J

T3D
Nucleotide
Protein
Nucleotide
Protein
Nucleotide
Protein
Nucleotide
Protein
L1 90 98 75 92 90 98 97 99
L2 86 97 73 87 77 93 97 98
L3 84 98 77 95 84 98 97 99
M1 92 97 70 80 92 96 90 95
M2 85 98 76 97 90 98 97 99
M3 85 95 71 82 85 95 97 98
S1 58 46 62 62 42 26 42 25
S2 85 98 76 94 85 98 88 98
S3 91 97 74 86 85 97 91 99
S4 87 97 79 91 87 96 95 99

*T1L, type 1 Lang; TJ2, type 2 Jones ; T3D, type 3 Dearing; L, large segment; M, medium segment; S, small segment.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO